Fluorescent Bacterial Magnetic Nanoparticles as Bimodal Contrast Agents
- 1 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 42 (4) , 235-241
- https://doi.org/10.1097/01.rli.0000255832.44443.e7
Abstract
Objectives: The purpose of this study was to assess whether fluorochrome-coupled bacterial magnetic nanoparticles can be used as bimodal contrast agent for both magnetic resonance imaging (MRI) and near-infrared fluorescence optical (NIRF) imaging of cultured macrophages. Materials and Methods: Bacterial magnetic nanoparticles (magnetosomes, particle diameter: 42 nm) were harvested from Magnetospirillum gryphiswaldense and characterized by using MRI. After covalent coupling to the fluorescent dye DY-676 (λabs./λem.= 676 nm/701 nm, Dyomics, Jena, Germany), the fluorescent magnetosomes were analyzed by fluorescence-activated cell sorting. Subsequently, murine macrophages J774 were incubated with the bimodal contrast agent (3 hours) and examined by a whole-body near infrared small animal imaging system as well as by using a 1.5 T clinical MR system. Moreover, labeled cells were characterized using confocal laser scanning microscopy (CLSM) and ultrathin section transmission electron microscopy. Results: Characterization of the nanoparticles by MRI revealed R1 and R2 relaxivities of 3.2 mM−1s−1 and 526 mM−1s−1, respectively. Fluorochrome-coupled magnetosomes exhibited increased fluorescence intensities at wavelengths >670 nm. Macrophages that were incubated with the contrast agent showed a significant fluorescence emission in the near infrared range as imaged with a whole body NIR imaging system, FACS analysis and CLSM. Moreover, CLSM data showed the greatest fluorescence intensities within intracellular compartments and colocalized with the magnetosomes. With MRI, both T1 and T2 relaxation times were substantially shortened at concentrations greater than 600 cells/μL. Discussion and Conclusion: Macrophages could be labeled with fluorescent magnetosomes, and they were successfully imaged using both a 1.5 T MR scanner as well as with NIRF optical methods. The use of this bimodal contrast agent for diagnostic purposes may benefit from the excellent spatial resolution of the MRI and the high sensitivity of the fluorescence imaging.Keywords
This publication has 26 references indexed in Scilit:
- Quantum Dots with a Paramagnetic Coating as a Bimodal Molecular Imaging ProbeNano Letters, 2005
- An acidic protein aligns magnetosomes along a filamentous structure in magnetotactic bacteriaNature, 2005
- Synthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials, 2005
- Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitroEuropean Radiology, 2004
- Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cellsEuropean Radiology, 2004
- Molecular imaging applications for immunologyClinical Immunology, 2004
- Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsEuropean Radiology, 2003
- Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imagingMagnetic Resonance in Medicine, 2003
- Growth and magnetosome formation by microaerophilic Magnetospirillum strains in an oxygen-controlled fermentorApplied Microbiology and Biotechnology, 2003
- Fortschritte in der optischen BildgebungDer Radiologe, 2001